| For: | Ahmed M. Era of direct acting anti-viral agents for the treatment of hepatitis C. World J Hepatol 2018; 10(10): 670-684 [PMID: 30386460 DOI: 10.4254/wjh.v10.i10.670] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i10/670.htm |
| Number | Citing Articles |
| 1 |
Lize Cuypers, Marijn Thijssen, Arash Shakibzadeh, Ward Deboutte, Jamal Sarvari, Farzaneh Sabahi, Mehrdad Ravanshad, Mahmoud Reza Pourkarim. Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran. Infection, Genetics and Evolution 2019; 75 doi: 10.1016/j.meegid.2019.103966
|
| 2 |
Khursheed ul Islam, Jawed Iqbal. Pathogenicity and Drug Resistance of Human Pathogens. 2019; doi: 10.1007/978-981-32-9449-3_12
|
| 3 |
Raquel Boff da Costa, Marisa Boff Costa, Larisse Longo, Daniela Elisa Miotto, Gustavo Hirata Dellavia, Matheus Trucollo Michalczuk, Mario Reis Álvares-da-Silva, Ahmed Negida. Direct antiviral agents for hepatitis C and drug interaction risk: A retrospective cohort study with real and simulated data on medication interaction, prevalence of comorbidities and comedications. PLOS ONE 2021; 16(2) doi: 10.1371/journal.pone.0245767
|
| 4 |
Sandhya Sharma, Emmanuel Thomas, Massimo Caputi, Waseem Asghar. RT-LAMP Based Molecular Diagnostic Set-Up for Rapid Hepatitis C Virus Testing. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4055777
|
| 5 |
Sandhya Sharma, Emmanuel Thomas, Massimo Caputi, Waseem Asghar. RT-LAMP-Based Molecular Diagnostic Set-Up for Rapid Hepatitis C Virus Testing. Biosensors 2022; 12(5) doi: 10.3390/bios12050298
|
| 6 |
Ahmed Emam, Khaled R. A. Abdellatif, Noha H. Amin, Khaled M. Elokely. HCV NS5B RdRp mutations and their effects on ligand binding affinity. International Journal of Modelling and Simulation 2022; 42(3) doi: 10.1080/02286203.2021.1923953
|
| 7 |
Masoud Keikha, Majid Eslami, Bahman Yousefi, Mohammad Ali-Hassanzadeh, Ali Kamali, Masoud Yousefi, Mohsen Karbalaei. HCV genotypes and their determinative role in hepatitis C treatment. VirusDisease 2020; 31(3) doi: 10.1007/s13337-020-00592-0
|
| 8 |
Vanessa Huffman, Diana C Andrade, Elizabeth Sherman, Jianli Niu, Paula A Eckardt. Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection. American Journal of Health-System Pharmacy 2021; 78(1) doi: 10.1093/ajhp/zxaa328
|
| 9 |
Zuhal Altintas, Engin Altintas. The Impact of Organic Anion-Transporting Polypeptide (OATP) Variants on the Side Effects of Direct-Acting Antivirals in Hepatitis C Patients. Cureus 2025; doi: 10.7759/cureus.82213
|
| 10 |
Jessica Williams-Nguyen, Stephen E Hawes, Robin M Nance, Sara Lindström, Susan R Heckbert, H Nina Kim, W Chris Mathews, Edward R Cachay, Matt Budoff, Christopher B Hurt, Peter W Hunt, Elvin Geng, Richard D Moore, Michael J Mugavero, Inga Peter, Mari M Kitahata, Michael S Saag, Heidi M Crane, Joseph A Delaney. Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States. American Journal of Epidemiology 2020; 189(6) doi: 10.1093/aje/kwz236
|
| 11 |
Yang Gao, Narayan Nepal, Shi-Zhu Jin. Toll-like receptors and hepatitis C virus infection. Hepatobiliary & Pancreatic Diseases International 2021; 20(6) doi: 10.1016/j.hbpd.2021.07.011
|
| 12 |
A. A. Savchenko, V. V. Tsukanov, I. V. Kudryavtsev, J. L. Tonkih, V. D. Belenjuk, M. A. Cherepnin, A. A. Anisimova, A. G. Borisov. A relation between T cell phenotypic profile and virus genotype in patients with chronic viral hepatitis (before and after treatment with direct antiviral agents). Russian Journal of Infection and Immunity 2021; 11(6) doi: 10.15789/2220-7619-ARB-1550
|
| 13 |
Ahreum Kim, Sung Jae Choi, Gwan Gyu Song, Joo-Hang Kim, Jae Hyun Jung. Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus. Clinical Rheumatology 2023; 42(10) doi: 10.1007/s10067-023-06597-6
|
| 14 |
Kelly G. Gwathmey, Jennifer A. Tracy, P. James B. Dyck. Peripheral Nerve Vasculitis. Neurologic Clinics 2019; 37(2) doi: 10.1016/j.ncl.2019.01.013
|
| 15 |
Yosuke Hashimoto, Yoshiaki Okada, Keisuke Shirakura, Keisuke Tachibana, Makoto Sawada, Kiyohito Yagi, Takefumi Doi, Masuo Kondoh. Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs. The Journal of Pharmacology and Experimental Therapeutics 2019; 368(2) doi: 10.1124/jpet.118.252361
|
| 16 |
Lili Liu, Mingyuan Zhang, Lei Hang, Fei Kong, Hongqing Yan, Yumei Zhang, Xiangwei Feng, Yuanda Gao, Chang Wang, Heming Ma, Xu Liu, Mengru Zhan, Yu Pan, Hongqin Xu, Junqi Niu. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection. Virology Journal 2020; 17(1) doi: 10.1186/s12985-020-1293-7
|
| 17 |
Roaa Khalil, Kholoud Al-Mahzoum, Muna Barakat, Malik Sallam. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences. Pathogens 2024; 13(8) doi: 10.3390/pathogens13080674
|